In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Zhifei Biological completes RMB1.4bn IPO on Shenzhen Exchange

Executive Summary

Chinese vaccines company Chongqing Zhifei Biological Products Co. Ltd. (Zhifei) has completed a 40mm-share IPO priced at RMB37.98 ($5.71), netting RMB1.43bn ($215mm). The company listed on the Shenzhen Exchange's Growth Enterprise Market (GEM) index.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies